MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

Table 1 Relationship between miR-192 expression and clinic-pathological characteristics of NPC patients

Characteristics	Cases	miR-192		P value
Characteristics	Cases	High	Low	P value
Age (years)				0.47
≥ 60	43	33	10
< 60	33	27	6
Gender				0.43
Male	45	32	13
Female	31	28	3
WHO type				0.06
I–II	28	18	10
III	48	42	6
Distant metastasis				0.03*
Yes	25	20	5
No	51	40	11
Tumor stage				0.02*
I–II	23	15	8
III–IV	53	45	18

ISSN: 1477-7819